New drug AZD5492 enters human safety trials for autoimmune diseases
NCT ID NCT06916806
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 22 times
Summary
This early-stage study tests the safety of a new drug called AZD5492 in 72 adults with lupus, myositis, or rheumatoid arthritis. Participants receive either one or two doses of the drug and are monitored for side effects over about 6 months. The goal is to find a safe dose and understand how the drug moves through the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGAnniston, Alabama, 36207, United States
-
Research Site
WITHDRAWNBirmingham, Alabama, 35233, United States
-
Research Site
NOT_YET_RECRUITINGLa Jolla, California, 92037, United States
-
Research Site
NOT_YET_RECRUITINGSacramento, California, 95817, United States
-
Research Site
RECRUITINGIowa City, Iowa, 52242, United States
-
Research Site
NOT_YET_RECRUITINGChapel Hill, North Carolina, 27599, United States
-
Research Site
NOT_YET_RECRUITINGHamilton, Ontario, L8S 4K1, Canada
-
Research Site
RECRUITINGSherbrooke, Quebec, J1G 2E8, Canada
-
Research Site
RECRUITINGBeijing, 100730, China
-
Research Site
RECRUITINGShanghai, 200001, China
-
Research Site
RECRUITINGWuhan, 430022, China
-
Research Site
NOT_YET_RECRUITINGZhengzhou, 450052, China
-
Research Site
RECRUITINGBordeaux, 33000, France
-
Research Site
RECRUITINGMontpellier, 34295, France
-
Research Site
RECRUITINGNancy, 54035, France
-
Research Site
RECRUITINGParis, 75013, France
-
Research Site
RECRUITINGStrasbourg, 67098, France
-
Research Site
RECRUITINGToulouse, 31059, France
-
Research Site
NOT_YET_RECRUITINGCologne, 50937, Germany
-
Research Site
NOT_YET_RECRUITINGErlangen, 91054, Germany
-
Research Site
NOT_YET_RECRUITINGMagdeburg, 39120, Germany
-
Research Site
RECRUITINGBunkyō City, 113-8655, Japan
-
Research Site
RECRUITINGKita-gun, 761-0793, Japan
-
Research Site
RECRUITINGKitakyushu-shi, 807-8555, Japan
-
Research Site
RECRUITINGKyoto, 606-8501, Japan
-
Research Site
RECRUITINGNagasaki, 852-8501, Japan
-
Research Site
RECRUITINGAmsterdam, 1105 AZ, Netherlands
-
Research Site
WITHDRAWNLeiden, 2333, Netherlands
-
Research Site
RECRUITINGMérida, 06800, Spain
-
Research Site
RECRUITINGSeville, 41010, Spain
-
Research Site
RECRUITINGValladolid, 47012, Spain
-
Research Site
RECRUITINGGlasgow, G31 2ER, United Kingdom
-
Research Site
RECRUITINGLondon, SE5 9RS, United Kingdom
-
Research Site
RECRUITINGLondon, WC1E 6JF, United Kingdom
-
Research Site
RECRUITINGSouthampton, SO16 6YD, United Kingdom
Conditions
Explore the condition pages connected to this study.